Leading oncology company Incanthera has launched a partnership with global investment group Technomark Life Sciences. The two businesses will work together to prepare ICT2588 - Incanthera’s revolutionary treatment for solid tumours ...
Tags: Life Sciences, clinical trials, medical
Merck has signed a licensing agreement with AiCuris for the worldwide development and commercialisation rights of candidates in AiCuris' Human Cytomegalovirus (HCMV) portfolio. The HCMV portfolio includes letermovir (AIC246), an oral, ...